Home
Tag
Pascal Soriot
1 article
Results
AstraZeneca Q2 EPS $2.63 Beats Forecast
Core earnings per share rose 18% to $2.63, surpassing analyst expectation of $2.48, while revenue grew 5% to $15.38 bn (constant currency). Operating profit reached $3.16 bn, pre‑tax profit $2.8 bn, d